Endometrial cancer (EC) incidence is comparable to CRC, being the cumulative incidences at 75 years by genes 37, 48.9, 41.1 and 12.8% for MLH1, MSH2, MSH6 and PMS2 mutation carriers, respectively. The gene discussed is PMS2; the disease is colorectal carcinoma.